Add BrightSurf on Google Email

Estrogen fails test as Alzheimer's treatment

A study published in Neurology found that estrogen had no effect on improving memory and mental functions in postmenopausal women with mild to moderate Alzheimer's disease after a 12-week period. Researchers suggest further trials are needed to determine the effectiveness of estrogen in preventing or delaying the onset of Alzheimer's.

SourceAmerican Academy of Neurology·JournalNeurology·DateJun 12, 2000

Estrogen may play role in prevention of cataracts

Researchers found that estrogen can reduce the risk of developing cataracts by up to 77%, with estradiol and estrone showing particular promise. The study used rats with induced ovarian failure to test the effects of different estrogens on cataract development.

SourceIndiana University·JournalProceedings of the National Academy of Sciences·DateOct 6, 1999

Red Wine's Health Benefits May Be Due In Part To

Researchers at Northwestern University Medical School found that resveratrol in red wine is a form of estrogen with cardioprotective properties. Moderate consumption of red wine may reduce cardiovascular disease risk due to its resveratrol content, which activates estrogen receptors and increases HDL cholesterol.

SourceNorthwestern University·JournalProceedings of the National Academy of Sciences·DateDec 17, 1997

University Of Washington Scientists Look For Cellular Clues To Explain How Estrogen Replacement Therapy May Protect Against Alzheimer's Disease

University of Washington scientists investigate how estrogen replacement therapy protects against Alzheimer's disease by promoting neuron survival and protecting against toxic substances. They found that estrogen may activate an enzyme to increase the expression of neurotransmitter genes, facilitating learning and memory.